Tumor byproduct blocks immune cells from battling cancer, offering new medication aim

A crew of researchers from the College of Chicago, in collaboration with researchers from the College of Pittsburgh, has identified a novel oncometabolite that accumulates in tumors and impairs immune cells’ ability to fight cancer…
Study More